Dr. Reddy's gets 5 observations from USFDA for Srikakulam formulations facility [Healthcare]
AI Summary1 min read
TL;DR
Dr. Reddy's received 5 observations from the USFDA for its Srikakulam formulations facility. The company is a global pharmaceutical firm with diverse product offerings and major markets worldwide.
Tags
Pharmaceuticals & DrugsHealthcareDr. Reddy'sUSFDASrikakulampharmaceuticalformulations
The company is a multinational pharmaceutical company that manufactures and markets a wide range of pharmaceutical products and services. Through its businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the Company offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), generics, biosimilars and differentiated formulations. The company offers a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Its major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its major markets include – USA, India, Russia & CIS countries, China, Brazil and Europe.